Here are what the editors at HealthDay consider to be the most important developments in Neurology for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Case Description Can Reliably Define Acute Flaccid Myelitis
FRIDAY, Nov. 30, 2018 (HealthDay News) — A case description can reliably define patients with acute flaccid myelitis (AFM), according to a study published online Nov. 30 in JAMA Pediatrics.
Abstract/Full Text
Editorial 1
Editorial 2
Results of Pediatric Genomic Epilepsy Tests Often Reclassified
FRIDAY, Nov. 30, 2018 (HealthDay News) — The interpretation of genomic epilepsy tests has evolved rapidly in the last five years, and genetic variants identified in pediatric patients are often reclassified, according to research published online Nov. 5 in JAMA Pediatrics.
Abstract/Full Text (subscription or payment may be required)
Burnout, Satisfaction Vary With Age, Sex Among Neurologists
FRIDAY, Nov. 30, 2018 (HealthDay News) — Burnout, career satisfaction, and well-being vary by age and sex among neurologists, according to a study published online Nov. 15 in Neurology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
FDA Approves Firdapse for Rare Autoimmune Disorder
THURSDAY, Nov. 29, 2018 (HealthDay News) — Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS).
Dementia Often Misclassified With Brief Cognitive Assessments
THURSDAY, Nov. 29, 2018 (HealthDay News) — When using brief cognitive assessments, dementia is often misclassified, according to a study published online Nov. 28 in Neurology Clinical Practice.
Abstract/Full Text (subscription or payment may be required)
Monitoring Movement Reflects Efficacy of Mandibular Splint
THURSDAY, Nov. 29, 2018 (HealthDay News) — For individuals with obstructive sleep apnea (OSA) treated with an optimally titrated mandibular advancement splint, normalization of the respiratory effort index derived from vertical mandibular movements (MM-REI) reflects the efficacy of the appliance, according to a study published online Nov. 6 in CHEST.
Abstract/Full Text (subscription or payment may be required)
Liquid Biopsy Can Assess Tx Response of Peds Brain Tumors
THURSDAY, Nov. 29, 2018 (HealthDay News) — A liquid biopsy using blood or cerebrospinal fluid (CSF) can effectively quantify changes in mutation levels among pediatric patients being treated for diffuse midline gliomas (DMGs), according to a study recently published in Clinical Cancer Research.
Abstract/Full Text (subscription or payment may be required)
ADHD Diagnosis, Treatment Up for August-Born Children
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021 
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy 
Frequent TV Watching Linked to Smaller Brain Volume 
ADHD Poses Additional Concussion Challenges for Athletes 
Extreme Heat Linked to 33 Clinically Reportable Diagnoses 
Problematic Social Media Use Linked to Worsening of ADHD Symptoms 
High Levels of Light Exposure Linked to Lower Dementia Risk .jpeg)
Neurodegenerative Mortality Elevated for NFL Athletes 
.jpg)